Status:
COMPLETED
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis
Lead Sponsor:
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
20-80 years
Phase:
PHASE1
Brief Summary
The aim of the investigators study was to investigate the safety and efficacy of autologous ADSCs for the clinical treatment of liver cirrhosis.
Detailed Description
One milliliter of cell suspension will be injected intrahepatically under sonographic guidance using a gauge-18 needle.
Eligibility Criteria
Inclusion
- Liver cirrhosis investigators with age 20 to 80 years (both inclusive).
- Investigators without Mandatory Communicable Disease (HBV, HCV, HIV, syphilis)
- Investigators without rare disorder
- Coagulation normalities
- Investigators without autoimmune disorder
- Investigators without Acquired Immune Deficiency Syndrome
- Investigators without cancer
- Investigators BMI \> 15
Exclusion
- Pregnant women
- Investigators with acute stroke in one month and unconsciousness
- Investigators with acute myocardial infarction or acute heart failure
- Investigators with serious liver dysfunction and coagulation dysfunction and ascites mild higher
- Investigators with acute respiratory failure or pneumonia
- Kidney Failure: BUN \> 50
- Anemia: Hematocrit \< 25
- Investigators diagnosed with liver cancer or liver metastatic carcinoma
- Investigators with liver abscess
- Investigators with acute Hepatitis
- Investigators with acute infective
- Liver cirrhosis patients with HBV or HCV
- Investigators diagnosed with carcinoma and receiving treatment
- Investigators with Schizophrenia or melancholia
- Investigators received serious surgical operations in 3 months
- Investigators unable to control hypertension (SBP \> 180 mmHg, DBP \> 110 mmHg) or diabetes (AC sugar \> 200 mg/dl)
- Others can't fit into the trial evaluate by investigator
Key Trial Info
Start Date :
July 13 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 27 2018
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT02297867
Start Date
July 13 2015
End Date
March 27 2018
Last Update
April 17 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Beigang Hospital
Taichung, Beigang, Taiwan, 65152
2
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Hsinchu, Taiwan, 30261